Literature DB >> 16009672

How do NHS general hospitals in England deal with patients with alcohol-related problems? A questionnaire survey.

Lynn Owens1, Ian T Gilmore, Munir Pirmohamed.   

Abstract

AIMS: Alcohol-related disease represents a major burden on hospitals. However, it is unclear whether hospitals have developed the necessary expertise and guidelines to deal with this burden. The aim of this survey was to determine what measures general hospital NHS Trusts in England had in place to deal with alcohol-related problems, including the employment of dedicated alcohol specialist nurses.
METHODS: Two postal surveys of all NHS general hospital Trusts in England, the first in 2000 (n = 138; 54% response rate) and the second in 2003 after the publication of the Royal College of Physicians (RCP) report on alcohol in secondary care (n = 164; 75% response rate).
RESULTS: Between the two surveys, there was a significant increase (P = 0.005) in the number of dedicated alcohol nurses employed by general hospital trusts; however, the numbers remain low (n = 21). Additionally, the availability of prescribing guidelines for the management of alcohol withdrawal increased significantly (P = 0.0001).
CONCLUSIONS: The survey indicates that most general hospitals do not have appropriate services in place to deal with such patients. Although there is a need and willingness to develop alcohol services in general hospitals, which is one of the key recommendations of the RCP report, the lack of funding is going to act as a major barrier.

Entities:  

Mesh:

Year:  2005        PMID: 16009672     DOI: 10.1093/alcalc/agh184

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  2 in total

1.  Tackling alcohol misuse at the front line.

Authors:  Robin Touquet; Alex Paton
Journal:  BMJ       Date:  2006-09-09

2.  Alcohol: a missed opportunity. A survey of all accident and emergency departments in England.

Authors:  R Patton; J Strang; C Birtles; M J Crawford
Journal:  Emerg Med J       Date:  2007-08       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.